Loading...
Loading...
Browse all stories on DeepNewz
VisitOutcome of Debates on NIH Study Transparency by End of 2024?
Policy change on publication mandates • 25%
No policy change • 25%
Public apology or statement from NIH • 25%
Other outcome • 25%
Official statements or policy changes from NIH or related institutions
Dr. Olson-Kennedy Withholds $9.7M NIH Study Showing Puberty Blockers Don't Improve Mental Health
Oct 23, 2024, 05:13 PM
A recent investigation revealed that a U.S. study on puberty blockers, led by Dr. Johanna Olson-Kennedy of Children's Hospital Los Angeles, has remained unpublished for nine years due to concerns over political ramifications. The study, funded by the National Institutes of Health (NIH) with $9.7 million, involved 70 transgender youth and aimed to assess the impact of puberty blockers on mental health outcomes. Reports indicate that the study found puberty blockers did not lead to significant improvements in mental health among participants. Dr. Olson-Kennedy reportedly stated, "I do not want our work to be weaponized," expressing concern that the findings could be misused by opponents of gender-affirming care. The New York Times highlighted this issue, prompting debates over transparency and the ethical responsibility to publish publicly funded research.
View original story
Study published • 25%
NIH takes action • 25%
Congressional hearing held • 25%
No significant outcome • 25%
Study published without consequences • 25%
Study published with consequences for Dr. Olson-Kennedy • 25%
Study remains unpublished • 25%
Other outcome • 25%
Passes by Majority • 33%
Fails to Pass • 33%
Postponed/Delayed • 33%
No censorship found • 25%
Partial censorship found • 25%
Full censorship found • 25%
Inconclusive • 25%
Support Dr. Olson-Kennedy's decision • 25%
Criticize the withholding of results • 25%
Call for policy changes in research transparency • 25%
Other • 25%
No Action Taken • 25%
Publication Mandated • 25%
Funding Reallocation • 25%
Other Outcome • 25%
Yes • 50%
No • 50%
Other consequence • 25%
Increased scrutiny on NIH studies • 25%
Changes in gender-affirming care policies • 25%
No significant consequence • 25%